Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

House Speaker Nancy Pelosi and Senate Majority Leader Mitch McConnell. Photo: Drew Angerer/Getty Images

28 days after the House voted to impeach President Trump, two articles and seven House managers will officially move over to the Senate for the third impeachment trial in U.S. history.

Why it matters: Barring a last-minute mutiny, Trump will be acquitted — but new information that the trial brings to light could prove politically damaging, both for the president and the Republican senators who have sought to protect him.

Driving the news: Under the resolution passed today, impeachment managers have "broad authority to submit to the Senate any additional evidence the House may acquire on its own," according to Judiciary Chairman Jerry Nadler (D-N.Y.)

  • That authority was teased last night with the release of a tranche of records from Lev Parnas, including a letter from Rudy Giuliani requesting a meeting with Ukraine's president "as personal counsel to President Trump and with his knowledge and consent."
  • House Democrats are also continuing to litigate a subpoena for former White House counsel Don McGahn, whose testimony they believe could bolster allegations of a pattern of obstructive conduct by Trump.
  • Outside the halls of Congress, investigative reporting and freedom of information of requests by independent watchdogs continue to yield new records and connect missing dots in the Trump-Ukraine affair.

The other side: A senior administration official told reporters on a call today that the White House doesn't believe the Senate needs to hear from any new witnesses, arguing that it would simply show that House Democrats didn't come "ready to present their case."

  • The official predicted that the trial would take roughly two weeks and culminate in an acquittal by Feb. 4, when Trump is due to give his State of the Union address.

Go deeper: Pelosi taps Schiff and Nadler among 7 House impeachment managers

Go deeper

USAID chief tests positive for coronavirus

An Air Force cargo jet delivers USAID supplies to Russia earlier this year. Photo: Mikhail Metzel/TASS via Getty Images

The acting administrator of the United States Agency for International Development informed senior staff Wednesday he has tested positive for coronavirus, two sources familiar with the call tell Axios.

Why it matters: John Barsa, who staffers say rarely wears a mask in their office, is the latest in a series of senior administration officials to contract the virus. His positive diagnosis comes amid broader turmoil at the agency following the election.

Bryan Walsh, author of Future
6 hours ago - Health

COVID-19 shows a bright future for vaccines

Illustration: Annelise Capossela/Axios

Promising results from COVID-19 vaccine trials offer hope not just that the pandemic could be ended sooner than expected, but that medicine itself may have a powerful new weapon.

Why it matters: Vaccines are, in the words of one expert, "the single most life-saving innovation ever," but progress had slowed in recent years. New gene-based technology that sped the arrival of the COVID vaccine will boost the overall field, and could even extend to mass killers like cancer.

7 hours ago - Health

Beware a Thanksgiving mirage

Illustration: Sarah Grillo/Axios

Don't be surprised if COVID metrics plunge over the next few days, only to spike next week.

Why it matters: The COVID Tracking Project warns of a "double-weekend pattern" on Thanksgiving — where the usual weekend backlog of data is tacked on to a holiday.